Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 24;9(9):CD010546.
doi: 10.1002/14651858.CD010546.pub2.

Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis

Juan Cristóbal Gana  1 , Lorena I Cifuentes, Daniela Gattini, Luis A Villarroel Del Pino, Alfredo Peña, Romina Torres-Robles
Affiliations

Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis

Juan Cristóbal Gana et al. Cochrane Database Syst Rev. .

Abstract

Background: Portal hypertension commonly accompanies advanced liver disease and often gives rise to life-threatening complications, including haemorrhage from oesophageal and gastrointestinal varices. Variceal haemorrhage commonly occurs in children with chronic liver disease or portal vein obstruction. Prevention is therefore important. Following numerous randomised clinical trials demonstrating efficacy of non-selective beta-blockers and endoscopic variceal ligation in decreasing the incidence of variceal haemorrhage, primary prophylaxis of variceal haemorrhage in adults has become the established standard of care. Hence, band ligation and beta-blockers have been proposed to be used as primary prophylaxis of oesophageal variceal bleeding in children.

Objectives: To determine the benefits and harms of band ligation compared with any type of beta-blocker for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.

Search methods: We searched The Cochrane Hepato-Biliary Group Controlled Trials Register (February 2019), CENTRAL (December 2018), PubMed (December 2018), Embase Ovid (December 2018), LILACS (Bireme; January 2019), and Science Citation Index Expanded (Web of Science; December 2018). We scrutinised the reference lists of the retrieved publications and performed a manual search from the main paediatric gastroenterology and hepatology conferences (NASPGHAN and ESPGHAN) abstract books from 2009 to 2018. We searched ClinicalTrials.gov for ongoing clinical trials. There were no language or document type restrictions.

Selection criteria: We planned to include randomised clinical trials irrespective of blinding, language, or publication status for assessment of benefits and harms. We planned to also include quasi-randomised and other observational studies retrieved with the searches for randomised clinical trials for report of harm.

Data collection and analysis: We planned to summarise data from randomised clinical trials using standard Cochrane methodologies.

Main results: We found no randomised clinical trials assessing band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.

Authors' conclusions: Randomised clinical trials assessing the benefits or harms of band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis are lacking. There is a need for well-designed, adequately powered randomised clinical trials to assess the benefits and harms of band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Those randomised clinical trials should include patient-relevant clinical outcomes such as mortality, failure to control bleeding, and adverse events.

PubMed Disclaimer

Conflict of interest statement

JCG: none. LC: none. DG: none. LV: none. AP: none. RTR: none.

Figures

1
1
Study flow diagram.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD010546

References

References to studies excluded from this review

Biecker 2009 {published data only}
    1. Biecker E, Classen L, Sauerbruch T, Schepke M. Does therapy of oesophageal varices influences the progression of varices? European Journal of Gastroenterology & Hepatology 2009;21(7):751-5. [PMID: ] - PubMed
Drastich 2005 {published data only}
    1. Drastich P, Spicak J, Petrtyl J, Bruha R, Lata J, Pribramska V, et al. Endoscopic ligation of the esophageal varices compared with beta-blockers for prophylaxis of the first bleeding in patients with liver cirrhosis. Ceska a Slovenska Gastroenterologie a Hepatologie 2005;59(3):116-21.
Drastich 2011 {published data only}
    1. Drastich P, Lata J, Petrtyl J, Bruha R, Prochazka V, Vanasek T, et al. Endoscopic variceal band ligation compared with propranolol for prophylaxis of first variceal bleeding. Annals of Hepatology 2011;10(2):142-9. [PMID: ] - PubMed
Lo 2004 {published data only}
    1. Lo GH, Chen WC, Chen MH, Lin CP, Lo CC, Hsu PI, et al. Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointestinal Endoscopy 2004;59(3):333-8. [PMID: ] - PubMed
Miloh 2009 {published and unpublished data}
    1. Miloh TA, Turner D, Shneider BL, Parkar S, Arnon R, Suchy FJ, et al. Variceal bleeding in children with portal hypertension: 12 year experience at a Pediatric Liver transplant Center. Hepatology (Baltimore, Md.) 2009;50:760A-1A.
Norberto 2007 {published data only}
    1. Norberto L, Polese L, Cillo U, Grigoletto F, Burroughs AK, Neri D, et al. A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. Liver Transplantation 2007;13(9):1272-8. [PMID: ] - PubMed
Sarin 1999 {published data only}
    1. Sarin SK, Lamba GS, Kumar M, Misra A, Murthy NS. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. New England Journal of Medicine 1999;340(13):988-93. [PMID: ] - PubMed
Sarin 2010 {published data only}
    1. Sarin SK, Gupta N, Jha SK, Agrawal A, Mishra SR, Sharma BC, et al. Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension. Gastroenterology 2010;139(4):1238-45. [PMID: ] - PubMed
Shang 2010 {published data only}
    1. Shang ZH, Chen HY, Dong HL. Application of timolol in preventing variceal hemorrhage in patients with portal hypertension. Acta Academiae Medicinae Sinicae 2010;32(5):553-6. [PMID: ] - PubMed
Thuluvath 2005 {published data only}
    1. Thuluvath PJ, Maheshwari A, Jagannath S, Arepally A. A randomized controlled trial of beta-blockers versus endoscopic band ligation for primary prophylaxis: a large sample size is required to show a difference in bleeding rates. Digestive Diseases and Sciences 2005;50(2):407-10. [PMID: ] - PubMed

Additional references

Bambha 2008
    1. Bambha K, Kim WR, Pedersen R, Bida JP, Kremers WK, Kamath PS. Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis. Gut 2008;57(6):814-20. [PMID: ] - PubMed
Blasco 2006
    1. Blasco A, Forns X, Carrion JA, Garcia-Pagan JC, Gilabert R, Rimola A, et al. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology (Baltimore, Md.) 2006;43(3):492-9. [PMID: ] - PubMed
Carbonell 2004
    1. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology (Baltimore, Md.) 2004;40(3):652-9. [PMID: ] - PubMed
Carneiro 2018
    1. Carneiro de Moura M, Chen S, Kamath BM, Ng VL, Ling SC. Acute Variceal Bleeding Causes Significant Morbidity. Journal of Pediatric Gastroenterology and Nutrition 2018;67(3):371-6. [PMID: ] - PubMed
Celinska‐Cedro 2003
    1. Celinska-Cedro D, Teisseyre M, Woynarowski M, Socha P, Socha J, Ryzko J. Endoscopic ligation of esophageal varices for prophylaxis of first bleeding in children and adolescents with portal hypertension: preliminary results of a prospective study. Journal of Pediatric Surgery 2003;38(7):1008-11. [PMID: ] - PubMed
Chan 2013
    1. Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (Clinical Research Ed.) 2013;346:e7586. [PMID: ] - PMC - PubMed
Cifuentes 2021a
    1. Cifuentes LI, Gattini D, Torres-Robles R, Gana JC. Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews 2021, Issue 1. Art. No: CD011561. [DOI: 10.1002/14651858.CD011561.pub2] - DOI - PMC - PubMed
Cifuentes 2021b
    1. Cifuentes LI, Gattini D, Torres-Robles R, Gana JC. Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews 2021, Issue 1. Art. No: CD011973. [DOI: 10.1002/14651858.CD011973.pub2] - DOI - PMC - PubMed
D'Amico 1995
    1. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology (Baltimore, Md.) 1995;22(1):332-54. [PMID: ] - PubMed
D'Amico 1999
    1. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Seminars in Liver Disease 1999;19(4):475-505. [PMID: ] - PubMed
D'Amico 2003
    1. D'Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology (Baltimore, Md.) 2003;38(3):599-612. [PMID: ] - PubMed
D'Amico 2006
    1. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. Journal of Hepatology 2006;44(1):217-31. [PMID: ] - PubMed
Duche 2010
    1. Duche M, Ducot B, Tournay E, Fabre M, Cohen J, Jacquemin E, et al. Prognostic value of endoscopy in children with biliary atresia at risk for early development of varices and bleeding. Gastroenterology 2010;139(6):1952-60. [PMID: ] - PubMed
Duche 2013
    1. Duche M, Ducot B, Ackermann O, Baujard C, Chevret L, Frank-Soltysiak M, et al. Experience with endoscopic management of high-risk gastroesophageal varices, with and without bleeding, in children with biliary atresia. Gastroenterology 2013;145(4):801-7. [PMID: ] - PubMed
Duche 2017
    1. Duche M, Ducot B, Ackermann O, Guerin F, Jacquemin E, Bernard O. Portal hypertension in children: high-risk varices, primary prophylaxis and consequences of bleeding. Journal of Hepatology 2017;66(2):320-7. [PMID: ] - PubMed
Eroglu 2004
    1. Eroglu Y, Emerick KM, Whitingon PF, Alonso EM. Octreotide therapy for control of acute gastrointestinal bleeding in children. Journal of Pediatric Gastroenterology and Nutrition 2004;38(1):41-7. [PMID: ] - PubMed
Gana 2011a
    1. Gana JC, Valentino PL, Morinville V, O'Connor C, Ling SC. Variation in care for children with esophageal varices: a study of physicians', patients', and families' approaches and attitudes. Journal of Pediatric Gastroenterology and Nutrition 2011;52(6):751-5. [PMID: ] - PubMed
Gana 2011b
    1. Gana JC. Primary prophylactic treatment of esophageal varices in pediatrics. Revista Chilena de Pediatría 2011;82(5):381-7.
Gana 2020
    1. Gana JC, Cifuentes LI, Gattini D, Torres-Robles R. Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews 2020, Issue 11. Art. No: CD011803. [DOI: 10.1002/14651858.CD011803.pub2] - DOI - PMC - PubMed
Garcia‐Tsao 2007
    1. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. American Journal of Gastroenterology 2007;102(9):2086-102. [PMID: ] - PubMed
Garcia‐Tsao 2008
    1. Garcia-Tsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding – unresolved issues. Summary of an American Association for the Study of Liver Diseases and European Association for the Study of the Liver single-topic conference. Hepatology (Baltimore, Md.) 2008;47(5):1764-72. [PMID: ] - PubMed
Garcia‐Tsao 2017
    1. Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology (Baltimore, Md.) 2017;65(1):310-35. [PMID: ] - PubMed
Gattini 2020a
    1. Gattini D, Cifuentes LI, Torres-Robles R, Gana JC. Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews 2020, Issue 1. Art. No: CD011659. [DOI: 10.1002/14651858.CD011659.pub2] - DOI - PMC - PubMed
Gattini 2020b
    1. Gattini D, Cifuentes LI, Torres-Robles R, Gana JC. Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews 2020, Issue 3. Art. No: CD011573. [DOI: 10.1002/14651858.CD011573.pub2] - DOI - PMC - PubMed
Ge 2014
    1. Ge PS, Runyon BA. The changing role of beta-blocker therapy in patients with cirrhosis. Journal of Hepatology 2014;60(3):643-53. [PMID: ] - PubMed
Gluud 2012
    1. Gluud LL, Krag A. Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults. Cochrane Database of Systematic Reviews 2012, Issue 8. Art. No: CD004544. [DOI: 10.1002/14651858.CD004544.pub2] [PMID: ] - DOI - PMC - PubMed
Goncalves 2000
    1. Goncalves ME, Cardoso SR, Maksoud JG. Prophylactic sclerotherapy in children with esophageal varices: long-term results of a controlled prospective randomized trial. Journal of Pediatric Surgery 2000;35(3):401-5. [PMID: ] - PubMed
GRADEpro GDT [Computer program]
    1. McMaster University (developed by Evidence Prime) GRADEpro GDT. Version accessed 4 December 2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. Available at gradepro.org.
Groszmann 2004
    1. Groszmann RJ, Bosch J. Portal Hypertension in the 21st Century. Dordrecht (The Netherlands): Kluwer Academic Publishers, 2004.
Hayes 1990
    1. Hayes PC, Davis JM, Lewis JA, Bouchier IA. Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet 1990;336(8708):153-6. [PMID: ] - PubMed
Higgins 2002
    1. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58. [PMID: ] - PubMed
Higgins 2003
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical Research Ed.) 2003;327(7414):557-60. [PMID: ] - PMC - PubMed
Higgins 2011
    1. Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Hobolth 2010
    1. Hobolth L, Krag A, Bendtsen F. The recent reduction in mortality from bleeding oesophageal varices is primarily observed from days 1 to 5. Liver International 2010;30(3):455-62. [PMID: ] - PubMed
ICH‐GCP 1997
    1. International Conference on Harmonisation Expert Working Group. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice CFR & ICH Guidelines. Vol. 1. Philadelphia (PA): Barnett International/PAREXEL, 1997.
Imperiale 2001
    1. Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology (Baltimore, Md.) 2001;33(4):802-7. [PMID: ] - PubMed
Jairath 2014
    1. Jairath V, Rehal S, Logan R, Kahan B, Hearnshaw S, Stanworth S, et al. Acute variceal haemorrhage in the United Kingdom: patient characteristics, management and outcomes in a nationwide audit. Digestive and Liver Disease 2014;46(5):419-26. [PMID: ] - PubMed
Jeanniard‐Malet 2017
    1. Jeanniard-Malet O, Duche M, Fabre A. Survey on clinical practice of primary prophylaxis in portal hypertension in children. Journal of Pediatric Gastroenterology and Nutrition 2017;64(4):524-7. [PMID: ] - PubMed
Jensen 2002
    1. Jensen DM. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology 2002;122(6):1620-30. [PMID: ] - PubMed
Kamath 2001
    1. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology (Baltimore, Md.) 2001;33(2):464-70. [PMID: ] - PubMed
Kjaergard 2001
    1. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-9. - PubMed
Kobayashi 1984
    1. Kobayashi A, Itabashi F, Ohbe Y. Long-term prognosis in biliary atresia after hepatic portoenterostomy: analysis of 35 patients who survived beyond 5 years of age. Journal of Pediatrics 1984;105(2):243-6. [PMID: ] - PubMed
Kovalak 2007
    1. Kovalak M, Lake J, Mattek N, Eisen G, Lieberman D, Zaman A. Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. Gastrointestinal Endoscopy 2007;65(1):82-8. [PMID: ] - PubMed
Lampela 2012
    1. Lampela H, Kosola S, Koivusalo A, Lauronen J, Jalanko H, Rintala R, et al. Endoscopic surveillance and primary prophylaxis sclerotherapy of esophageal varices in biliary atresia. Journal of Pediatric Gastroenterology and Nutrition 2012;55(5):574-9. [PMID: ] - PubMed
Ling 2011
    1. Ling SC, Walters T, McKiernan PJ, Schwarz KB, Garcia-Tsao G, Shneider BL. Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research. Journal of Pediatric Gastroenterology and Nutrition 2011;52(3):254-61. [PMID: ] - PMC - PubMed
Lui 2002
    1. Lui HF, Stanley AJ, Forrest EH, Jalan R, Hislop WS, Mills PR, et al. Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology 2002;123(3):735-44. - PubMed
Lykavieris 2000
    1. Lykavieris P, Gauthier F, Hadchouel P, Duche M, Bernard O. Risk of gastrointestinal bleeding during adolescence and early adulthood in children with portal vein obstruction. Journal of Pediatrics 2000;136(6):805-8. [PMID: ] - PubMed
McDiarmid 2002
    1. McDiarmid SV, Anand R, Lindblad AS. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 2002;74(2):173-81. [PMID: ] - PubMed
Merli 2003
    1. Merli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. Journal of Hepatology 2003;38(3):266-72. [PMID: ] - PubMed
Miga 2001
    1. Miga D, Sokol RJ, Mackenzie T, Narkewicz MR, Smith D, Karrer FM. Survival after first esophageal variceal hemorrhage in patients with biliary atresia. Journal of Pediatrics 2001;139(2):291-6. [PMID: ] - PubMed
Moher 1998
    1. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998;352(9128):609-13. - PubMed
Molleston 2013
    1. Molleston JP, Shneider BL. Preventing variceal bleeding in infants and children: is less more? Gastroenterology 2013;145(4):719-22. [PMID: ] - PubMed
Ozsoylu 2000
    1. Ozsoylu S, Kocak N, Demir H, Yuce A, Gurakan F, Ozen H. Propranolol for primary and secondary prophylaxis of variceal bleeding in children with cirrhosis. Turkish Journal of Pediatrics 2000;42(1):31-3. [PMID: ] - PubMed
PCORI 2012
    1. Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI). Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. JAMA 2012;307(15):1636-40. [PMID: ] - PubMed
Pimenta 2016
    1. Pimenta JR, Ferreira AR, Bittencourt PF, Resende CB, Fagundes ED, Silva IM. Evaluation of primary prophylaxis with propranolol and elastic band ligation in variceal bleeding in cirrhotic children and adolescents. Arquivos de Gastroenterologia 2016;53(4):257-61. [PMID: ] - PubMed
Pugh 1973
    1. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. British Journal of Surgery 1973;60(8):646-9. [PMID: ] - PubMed
Review Manager 2014 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Royle 2003
    1. Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591-603. - PubMed
Samanta 2011
    1. Samanta T, Purkait R, Sarkar M, Misra A, Ganguly S. Effectiveness of beta blockers in primary prophylaxis of variceal bleeding in children with portal hypertension. Tropical Gastroenterology 2011;32(4):299-303. [PMID: ] - PubMed
Savović 2012a
    1. Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. Health Technology Assessment 2012;16(35):1-82. - PubMed
Savović 2012b
    1. Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine 2012;157(6):429-38. - PubMed
Savović 2018
    1. Savović J, Turner RM, Mawdsley D, Jones HE, Beynon R, Higgins JP, et al. Association between risk-of-bias assessments and results of randomized trials in Cochrane Reviews: the ROBES Meta-Epidemiologic Study. American Journal of Epidemiology 2018;187(5):1113-22. - PMC - PubMed
Scaglione 2015
    1. Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A, et al. The epidemiology of cirrhosis in the United States: a population-based study. Journal of Clinical Gastroenterology 2015;49(8):690-6. [PMID: ] - PubMed
Schulz 1995
    1. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12. - PubMed
Serste 2010
    1. Serste T, Melot C, Francoz C, Durand F, Rautou PE, Valla D, et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology (Baltimore, Md.) 2010;52(3):1017-22. [PMID: ] - PubMed
Sharara 2001
    1. Sharara AI, Rockey DC. Gastroesophageal variceal hemorrhage. New England Journal of Medicine 2001;345(9):669-81. [PMID: ] - PubMed
Shashidhar 1999
    1. Shashidhar H, Langhans N, Grand RJ. Propranolol in prevention of portal hypertensive hemorrhage in children: a pilot study. Journal of Pediatric Gastroenterology and Nutrition 1999;29(1):12-7. [PMID: ] - PubMed
Shneider 2012
    1. Shneider BL, Bosch J, Franchis R, Emre SH, Groszmann RJ, Ling SC, et al. Portal hypertension in children: expert pediatric opinion on the report of the Baveno V Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension. Pediatric Transplantation 2012;16(5):426-37. [PMID: ] - PubMed
Shneider 2016
    1. Shneider BL, Ville de Goyet J, Leung DH, Srivastava A, Ling SC, Duche M, et al. Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: summary of the Baveno VI Pediatric Satellite Symposium. Hepatology (Baltimore, Md.) 2016;63(4):1368-80. [PMID: ] - PubMed
Stringer 1989
    1. Stringer MD, Howard ER, Mowat AP. Endoscopic sclerotherapy in the management of esophageal varices in 61 children with biliary atresia. Journal of Pediatric Surgery 1989;24(5):438-42. [PMID: ] - PubMed
Toyosaka 1993
    1. Toyosaka A, Okamoto E, Okasora T, Nose K, Tomimoto Y. Outcome of 21 patients with biliary atresia living more than 10 years. Journal of Pediatric Surgery 1993;28(11):1498-501. [PMID: ] - PubMed
van Heurn 2004
    1. Heurn LW, Saing H, Tam PK. Portoenterostomy for biliary atresia: long-term survival and prognosis after esophageal variceal bleeding. Journal of Pediatric Surgery 2004;39(1):6-9. [PMID: ] - PubMed
Verdaguer 2016
    1. Verdaguer DS, Gana AJ. Management of pediatric patients with esophageal varices [Enfrentamiento de pacientes pediatricos con varices esofagicas]. Revista Medica de Chile 2016;144(7):879-85. [PMID: ] - PubMed
Wetterslev 2009
    1. Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in a random-effects meta-analysis. BMC Medical Research Methodology 2009;9:86. - PMC - PubMed
Wood 2008
    1. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (Clinical Research Ed.) 2008;336:601-5. - PMC - PubMed

References to other published versions of this review

Gana 2013
    1. Gana JC, Cifuentes LI, Cerda J, Villarroel del Pino LA, Peña A, Rivera Cornejo M. Banding ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children. Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No: CD010546. [DOI: 10.1002/14651858.CD010546] - DOI - PMC - PubMed

Publication types

MeSH terms

Substances